TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07058883: Prospective, Randomized, Placebo-Controlled, Multicenter Clinical Trial Evaluating the Efficacy and Safety of Juläine (Polylactic Acid) in the Treatment of Facial Acne Scars

Sponsor: Nordberg Medical AB · Phase: PHASE2 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 55 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$2,967,000

Rescue Site Savings

+$1,960,800

Unlock Full NCT07058883 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07058883 Rescue Dossier →